Morgan Stanley analyst Drew Ranieri maintains Haemonetics (NYSE:HAE) with a Equal-Weight and raises the price target from $60 to $70.
Alphabet, Meta, Pinterest, And Snap Shares Catch Attention As New Coverage Initiated By Analysts
Large and mid-cap tech companies, specifically shares of Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL), Meta Platforms Inc (NASDAQ:META), Pinterest Inc…